XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a blank check company incorporated in Delaware and focused on the pharmaceutical and life sciences sector. The company completed its initial public offering in 2017 and filed a Form 10-Q with the SEC on November 14, 2017, reflecting its status as an operating shell company actively seeking a business combination target. Registered under CIK 0001697805, the company targeted acquisition candidates in the biopharmaceutical space, a sector that drew significant SPAC interest during that period. As of its November 2017 filing, the company remained in the pre-combination phase. Visit SpacDesk and sign up for full data, filings, and deal-status tracking on Xynomic Pharmaceuticals Holdings and hundreds of other SPAC vehicles.